Immunocompromised People and Covid-19 Clinical Trials
Help fill the void in scientific knowledge about Covid in immunocompromised people
If your immune system doesn’t work at full strength, you’re at higher risk for getting an infection or disease like Covid-19. It may not be your first thought to join a clinical trial that is studying new medicines or vaccines, but this type of research is key to protecting people who are immunocompromised.
What does “immunocompromised” mean?
Your immune system is designed to fight off infections and diseases. People who are “immunocompromised” have weakened immune systems. They may have a harder time fighting off viruses, bacteria and fungi that cause health problems.
What causes weakened immunity?
There are many reasons why your immune system might be weak, including:
Covid-19 threats to people with weakened immune systems
How to protect immunocompromised people from Covid-19
Why should immunocompromised people participate in clinical trials?
Are clinical trials safe for immunocompromised people?
Most clinical trials are carefully monitored by an Institutional Review Board or IRB. IRBs protect participants’ rights and make sure research studies are ethical and appropriate.
How to find a clinical trial for Covid-19 treatment
Clinicaltrials.gov
NIAID Covid-19 Studies
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA)
A Nasal Treatment for Covid-19
A Study to Evaluate EDP-235 in Non-Hospitalized Adults with Covid-19 (SPRINT)
This educational resource was created with support from AstraZeneca.
AstraZeneca COVID-19 Clinical Trial Materials for Immunocompromised People
Español
COVID-19 Clinical Trials
Clinical Trials for Immunocompromised People





Support Our Mission